Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig W Ritchie

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2017
Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's diseaseJames D Stefaniak, Li Su, Elijah Mak, et al.
Alzheimer'S Research & Therapy|October 21, 2016
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extensionLaura M Gault, Robert A Lenz, Craig W Ritchie, et al.
Brain Communications|March 6, 2024
Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia studySita N Shah, Maria-Eleni Dounavi, Paresh A Malhotra, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 3, 2021
Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia studyMaria-Eleni Dounavi, Audrey Low, Elizabeth F McKiernan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2016
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibilityMarion Mortamais, Jessica A Ash, John Harrison, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 23, 2026
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's diseaseBolin Cao, Qing Qi, Siobhan Hutchinson, et al.
Neurobiology of Aging|September 18, 2024
Cardiovascular risk of dementia is associated with brain-behaviour changes in cognitively healthy, middle-aged individualsFeng Deng, Maria-Eleni Dounavi, Emanuele R G Plini, et al.
International Journal of Geriatric Psychiatry|September 29, 2006
A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacementElizabeth L Sampson, Peter R Raven, Patricia N Ndhlovu, et al.
Brain Communications|January 31, 2020
Mechanical property alterations across the cerebral cortex due to Alzheimer's diseaseLucy V Hiscox, Curtis L Johnson, Matthew D J McGarry, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 9, 2024
Association of optic disc pallor and RNFL thickness with cerebral small vessel disease in the PREVENT-Dementia studySamuel Gibbon, Audrey Low, Charlene Hamid, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2017
Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's diseaseJames D Stefaniak, Li Su, Elijah Mak, et al.
Alzheimer'S Research & Therapy|October 21, 2016
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extensionLaura M Gault, Robert A Lenz, Craig W Ritchie, et al.
Brain Communications|March 6, 2024
Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia studySita N Shah, Maria-Eleni Dounavi, Paresh A Malhotra, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 3, 2021
Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia studyMaria-Eleni Dounavi, Audrey Low, Elizabeth F McKiernan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 6, 2016
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibilityMarion Mortamais, Jessica A Ash, John Harrison, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 23, 2026
The relative contribution of modifiable and non-modifiable factors for determining cognition in mid-life individuals at risk for late-life Alzheimer's diseaseBolin Cao, Qing Qi, Siobhan Hutchinson, et al.
Neurobiology of Aging|September 18, 2024
Cardiovascular risk of dementia is associated with brain-behaviour changes in cognitively healthy, middle-aged individualsFeng Deng, Maria-Eleni Dounavi, Emanuele R G Plini, et al.
International Journal of Geriatric Psychiatry|September 29, 2006
A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacementElizabeth L Sampson, Peter R Raven, Patricia N Ndhlovu, et al.
Brain Communications|January 31, 2020
Mechanical property alterations across the cerebral cortex due to Alzheimer's diseaseLucy V Hiscox, Curtis L Johnson, Matthew D J McGarry, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 9, 2024
Association of optic disc pallor and RNFL thickness with cerebral small vessel disease in the PREVENT-Dementia studySamuel Gibbon, Audrey Low, Charlene Hamid, et al.
Pageof 15